Manipal Health Enterpri L
Manipal Health Enterpri L (MANIPALHOS): company summary
The company's revenue grew 15.5% annually, but net profit fell 19.6% year-on-year.
Manipal Health Enterpri L (MANIPALHOS) is a mid-cap Healthcare company valued at ₹95,003 crore operating in Healthcare Services on the NSE and BSE.
- Recent price move
- Manipal Health Enterpri L last traded at ₹760.6, modestly up 1.94% on the day.
- Recent developments
- On 2026-08-07, the company's IPO was subscribed 5x on closing day, with a fresh issue of equity shares worth up to ₹8,000 crore and an offer for sale of up to 2.16 crore equity shares by existing shareholders. On 2026-08-05, the stock traded at ₹651, a 11% premium over the IPO price of ₹590, and the IPO listed with a grey market premium of around ₹3, indicating an estimated listing price of ₹593.
- Financial performance
- The company's revenue grew 15.5% annually, but net profit fell 19.6% year-on-year. In the latest quarter, revenue rose 28.1% compared to the same quarter a year earlier, but net profit dropped 7.9%. The net profit margin narrowed 5.2 percentage points to 12.0%, while return on equity remained at 8.6%.
- Valuation multiples
- The stock trades at 209.0 times earnings, a premium to the Healthcare median of 32.2, 5.87 times book value.
- Things to watch
- The stock is 12.0% below its 52-week high. Net profit margin fell 5.2 percentage points to 12.0%, and net profit declined 19.6% annually. The latest quarter saw a 7.9% drop in net profit despite a 28.1% rise in revenue.
- Where it stands
- The company's revenue grew 15.5% annually, but net profit fell 19.6% year-on-year. The latest quarter saw revenue rise 28.1% compared to the same quarter a year earlier, but net profit dropped 7.9%. The stock is 12.0% below its 52-week high, and the net profit margin narrowed 5.2 percentage points to 12.0%.
Summarised by DocStoX's model on 2026-09-12 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by risk (9.0) and growth (8.3), but held back by valuation (0.0). Risk looks strong at 9.0, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profit compounding 30% a year
- Profitable in all of the last 5 years
- Revenue compounding 21% a year
- Valuation is weak (0.0/10)
- Expensive at 200× earnings
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Healthcare Services
Explore MANIPAL HEALTH ENTERPRI L’s valuation
Free deep-dive tools · no sign-up
MANIPAL HEALTH ENTERPRI L peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare MANIPAL HEALTH ENTERPRI L with peers
Related tools & concepts
Value MANIPAL HEALTH ENTERPRI L with the ratios and calculators DocStoX uses in its analysis.

